Today: 10 April 2026
Subscribe
Browse Category

NASDAQ:ISRG 15 January 2026 - 4 February 2026

Intuitive Surgical stock (ISRG) ends week lower as insider trades surface; what to watch next

Intuitive Surgical stock (ISRG) ends week lower as insider trades surface; what to watch next

Intuitive Surgical shares fell 0.66% to $504.22 Friday, extending a two-day slide after a 2.78% drop Thursday. EVP Myriam Curet sold 126 shares at $520.02 each under a preset plan, while CEO David Rosa received performance stock units set to vest in 2026 and 2027. The company forecasts 2026 procedure growth of 13%-15% and a 67%-68% non-GAAP gross margin, factoring in a 1.2% tariff hit. Markets reopen Monday.
1 February 2026
ISRG stock slips after FDA clears da Vinci 5 for heart procedures; TD Cowen starts at Buy

ISRG stock slips after FDA clears da Vinci 5 for heart procedures; TD Cowen starts at Buy

Intuitive Surgical shares fell 0.7% to $525.09 Tuesday after the FDA cleared its da Vinci 5 robot for select cardiac procedures. The S&P 500 ETF rose 0.5% and QQQ gained 0.9%. TD Cowen initiated coverage with a Buy rating and $660 target, citing potential for expanded hospital adoption. Intuitive forecasts 13–15% da Vinci procedure growth in 2026, with a 1.2% revenue hit from tariffs.
27 January 2026
····
ISRG stock edges up after Intuitive Surgical wins FDA clearance for da Vinci 5 heart procedures

ISRG stock edges up after Intuitive Surgical wins FDA clearance for da Vinci 5 heart procedures

Intuitive Surgical shares rose about 1% after the FDA cleared its da Vinci 5 robot for select cardiac procedures. The company plans a limited U.S. rollout through 2026. The clearance follows last week’s warning of slower global procedure growth, with forecasts now at 13% to 15% for 2026. Investors are weighing the new approval against concerns over hospital budgets and rising competition.
26 January 2026
··
Intuitive Surgical stock price: what to watch Monday after ISRG’s 2026 da Vinci outlook and tariffs hit focus

Intuitive Surgical stock price: what to watch Monday after ISRG’s 2026 da Vinci outlook and tariffs hit focus

Intuitive Surgical shares closed at $523.99 Friday, down 0.4% after the company forecast da Vinci procedure growth of 13%–15% by 2026 and warned tariffs could pressure margins. Fourth-quarter revenue rose 19% to $2.87 billion, with adjusted earnings of $2.53 per share. The company reported over 20 million da Vinci procedures worldwide. FDA cleared new cardiac uses for its da Vinci 5 robot.
25 January 2026
··
Intuitive Surgical stock slips into weekend after earnings beat, with tariffs and 2026 outlook in focus

Intuitive Surgical stock slips into weekend after earnings beat, with tariffs and 2026 outlook in focus

Intuitive Surgical shares closed Friday at $523.99, down 0.4%, after the company beat quarterly estimates but projected slower da Vinci procedure growth and flagged higher tariff costs for 2026. The firm reported Q4 revenue of $2.87 billion and installed 532 da Vinci systems. U.S. markets remain closed until Monday. Investors focused on tariffs and hospital demand signals heading into next week.
25 January 2026
··
Intuitive Surgical stock price dips as 2026 da Vinci outlook cools after Q4 beat (ISRG)

Intuitive Surgical stock price dips as 2026 da Vinci outlook cools after Q4 beat (ISRG)

Intuitive Surgical shares fell 0.2% to $524.65 after the company forecast slower da Vinci procedure growth of 13–15% for 2026, down from 18% in 2025. Fourth-quarter revenue rose 19% to $2.87 billion, with adjusted profit topping estimates. Management cited tariff risks and rising competition as headwinds. The company installed 532 da Vinci systems in Q4, bringing its total to 11,106.
23 January 2026
··
Intuitive Surgical stock jumps premarket after earnings beat, but 2026 tariff hit gets attention

Intuitive Surgical stock jumps premarket after earnings beat, but 2026 tariff hit gets attention

Intuitive Surgical shares jumped 3.6% premarket to $545 after beating fourth-quarter estimates and reporting an 18% rise in global procedures. The company forecast slower 2026 procedure growth of 13%–15% and said tariffs would cut margins by about 1.2% of revenue. Traders are watching for analyst updates at the open. Cash and investments totaled $9.03 billion at year-end.
23 January 2026
··
Intuitive Surgical stock whipsaws after Q4 beat as 2026 da Vinci outlook and tariffs hit focus

Intuitive Surgical stock whipsaws after Q4 beat as 2026 da Vinci outlook and tariffs hit focus

Intuitive Surgical shares rose 0.4% to $525.81 in after-hours trading Thursday after quarterly earnings beat forecasts. The company reported a 19% revenue increase to $2.87 billion, with da Vinci procedures up 17%. Intuitive projects 13%-15% da Vinci procedure growth in 2026 but warned tariffs could cut margins. Investors remain focused on procedure growth and tariff impacts ahead of Friday’s session.
23 January 2026
···
Intuitive Surgical Q4 2025 earnings beat lifts ISRG, but 2026 da Vinci forecast slows on tariffs

Intuitive Surgical Q4 2025 earnings beat lifts ISRG, but 2026 da Vinci forecast slows on tariffs

Intuitive Surgical reported Q4 revenue up 19% to $2.87 billion and adjusted earnings of $2.53 per share, beating analyst estimates. Shares rose about 3% in after-hours trading. The company forecast 13% to 15% growth in da Vinci procedures for 2026, slower than 2025, and warned tariffs may pressure margins. Intuitive installed 532 da Vinci systems in the quarter, ending 2025 with 11,106 in use.
22 January 2026
··
Intuitive Surgical stock ticks up ahead of earnings after a bruising slide — what traders watch next

Intuitive Surgical stock ticks up ahead of earnings after a bruising slide — what traders watch next

Intuitive Surgical shares rose 0.9% to $528.38 Thursday ahead of fourth-quarter earnings, after a recent slide left the stock 14% below its 52-week high. Investors are focused on growth in da Vinci procedures for 2026 after last week’s cautious outlook. The company reported preliminary Q4 revenue of $2.87 billion, up 19% year over year. Results and management commentary are due after the bell.
22 January 2026
··
Intuitive Surgical stock slips as ISRG heads into key earnings call after softer 2026 outlook

Intuitive Surgical stock slips as ISRG heads into key earnings call after softer 2026 outlook

Intuitive Surgical shares fell 1.5% to $526.76 Tuesday afternoon, mirroring broader U.S. market declines. The company is set to report earnings Jan. 22 after signaling da Vinci procedure growth of 13%–15% in 2026 and preliminary Q4 revenue near $2.87 billion. Investors remain focused on procedure outlook and competition from Medtronic and Johnson & Johnson.
20 January 2026
··
Why Intuitive Surgical stock price is in focus: ISRG heads into earnings week after Friday dip

Why Intuitive Surgical stock price is in focus: ISRG heads into earnings week after Friday dip

Intuitive Surgical closed down 1.2% at $535 on Friday after forecasting 2026 da Vinci procedure growth of 13%–15%, below analyst expectations. Preliminary Q4 revenue was $2.87 billion, up 19% year over year, with 532 da Vinci systems placed. U.S. markets will reopen Tuesday after the Martin Luther King Jr. Day holiday. Shares may react further after the company’s Jan. 22 results.
19 January 2026
··
Intuitive Surgical stock (ISRG) heads into earnings week after Friday drop — what to watch next

Intuitive Surgical stock (ISRG) heads into earnings week after Friday drop — what to watch next

Intuitive Surgical shares fell 1.2% to $535 on Friday, marking five straight sessions of losses as trading volume rose. The company reported preliminary Q4 revenue of $2.87 billion, up 19% year-over-year, and a 17% increase in da Vinci procedures. CEO Dave Rosa said da Vinci 5 usage is 11% higher than the Xi model. Full Q4 results are due Jan. 22.
17 January 2026
··
Intuitive Surgical stock slips again as 2026 da Vinci outlook hangs over ISRG ahead of earnings

Intuitive Surgical stock slips again as 2026 da Vinci outlook hangs over ISRG ahead of earnings

Intuitive Surgical shares fell 0.9% to $536.49 in early New York trading Friday after the company’s 2026 da Vinci procedure-growth forecast missed some investor expectations. The company reported unaudited Q4 revenue of $2.87 billion, up 19%, and projected 2026 da Vinci procedure growth of 13% to 15%. Investors await more detail at the Jan. 22 earnings call.
16 January 2026
··
1 2 3

Stock Market Today

  • Nio Shares Drop 4.86% After Launching New ES9 Electric SUV
    April 9, 2026, 6:24 PM EDT. Chinese EV maker Nio (NYSE:NIO) saw its shares fall 4.86% to $6.07 following the debut of its ES9, billed as China's largest fully electric SUV. The stock traded heavily at 68.5 million shares, 52% above its 3-month average. Despite falling, Nio's shares have gained 27% in the past month amid strong delivery momentum and growth prospects heading into Q1 2026 results. The S&P 500 rose 0.62%, while peers Tesla and Li Auto showed mixed performances, up 0.69% and down 1.83%, respectively. Investors remain cautious, viewing today's drop as potential profit-taking rather than diminished confidence. Monitoring Nio's delivery updates and debt is crucial to assessing its growth sustainability. The Motley Fool's Stock Advisor, which excludes Nio, continues to recommend other top stocks with historic high returns.

Latest article

MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

9 April 2026
MARA Holdings shares rose 1.7% to $9.67 Thursday despite Cantor Fitzgerald cutting its price target to $10. The company recently sold 15,133 bitcoin for $1.1 billion and agreed to repurchase $1 billion in convertible notes at a discount. MARA is expanding into AI and cloud infrastructure, but fourth-quarter revenue fell 6% and it posted a $1.7 billion net loss.
CoreWeave secures fresh $21 billion Meta AI deal as debt push raises stakes

CoreWeave secures fresh $21 billion Meta AI deal as debt push raises stakes

9 April 2026
Meta Platforms signed a new $21 billion deal with CoreWeave for AI cloud computing capacity through 2032, according to a securities filing. CoreWeave shares rose 3.4% in after-hours trading. The agreement adds to a $14.2 billion commitment disclosed last September. CoreWeave also launched $3 billion in convertible notes and upsized a senior-notes deal to $1.75 billion.
Tesla Revives Cheaper EV Push With New Compact SUV as Sales Pressure Builds

Tesla Revives Cheaper EV Push With New Compact SUV as Sales Pressure Builds

9 April 2026
Tesla is developing a lower-cost compact SUV, with initial production planned for Shanghai, Reuters reported Thursday. The company built 408,386 vehicles and delivered 358,023 in the first quarter, leaving its widest gap in at least four years. Reuters said the new SUV likely will not reach production this year. Tesla did not respond to questions about the project.
NIO ES9 Price Starts at 528,000 Yuan as Flagship SUV Bet Faces China EV Slump

NIO ES9 Price Starts at 528,000 Yuan as Flagship SUV Bet Faces China EV Slump

9 April 2026
NIO opened pre-orders for its ES9 flagship SUV Thursday, pricing it at 528,000 yuan with battery or 420,000 yuan under its Battery-as-a-Service plan. March deliveries rose 136% year-on-year, but NIO’s U.S. shares fell 4.9% after the announcement. The ES9 enters a shrinking premium SUV market in China, competing with Li Auto and Aito. CEO William Li warned chip shortages could add up to 10,000 yuan per vehicle.
Plug Power Stock Climbs After 2026 Profit Push, Up to $200M Cost-Cut Plan

Plug Power Stock Climbs After 2026 Profit Push, Up to $200M Cost-Cut Plan

9 April 2026
Plug Power shares rose 2.5% to $2.715 Thursday after the company reaffirmed its target of positive EBITDAS by end-2026 and projected up to $200 million in savings from Project Quantum Leap. The update followed a major electrolyzer project win in Quebec and investor meetings in Toronto and Montreal. Plug reported 2025 revenue of $710 million and a fourth-quarter gross profit of $5.5 million.
Go toTop